About: Chapter 95 Management of Infection in Patients With Kidney Transplant

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Chapter 95 Management of Infection in Patients With Kidney Transplant Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Chapter 95 Management of Infection in Patients With Kidney Transplant
Creator	Cawcutt, Kelly Zimmer, Andrea
source	Elsevier; PMC
abstract	Abstract With the pervasive nature of chronic kidney disease, kidney transplantation is likely to continue to increase in the coming years. There are many infectious risks related to kidney transplant, including reactivation of latent infections, surgical complications, infectious risks related to immunosuppression, and nosocomial and community-acquired infections. These are described classically via timeline with early infections (first month), middle (1 to 6 months), and late (after 6 months). Kidney transplant patients may suffer from infections secondary to a vast array of organisms, including bacteria, fungi, and viruses. Certain infections, particularly viral infections such as cytomegalovirus, Epstein-Barr virus, and BK virus, may portend acute and chronic implications of the infection and its subsequent impact on graft function. Critical care physicians and nephrologists caring for patients with a renal transplant must understand the broad array of possible infections, atypical presentations, and nuanced implications for appropriate evaluation and subsequent therapy, combined with the need for possible prophylaxis and/or suppression. Multidisciplinary teams, including transplant physicians and infectious diseases physicians, are encouraged strongly.
has issue date	2019-12-31(xsd:dateTime)
bibo:doi	10.1016/b978-0-323-44942-7.00095-9
has license	els-covid
sha1sum (hex)	edf3b05c1aced395bde43ecf269fdc5e5a72a805
schema:url	https://doi.org/10.1016/b978-0-323-44942-7.00095-9
resource representing a document's title	Chapter 95 Management of Infection in Patients With Kidney Transplant
has PubMed Central identifier	PMC7152491
schema:publication	Critical Care Nephrology
resource representing a document's body	covid:edf3b05c1aced395bde43ecf269fdc5e5a72a805#body_text
is schema:about of	named entity 'Infection' named entity 'MANIFESTATIONS' named entity 'COMMON' named entity 'DESCRIBE' named entity 'INTENSIVE CARE UNIT' named entity 'RECOGNIZE' named entity 'RENAL TRANSPLANT RECIPIENTS' named entity 'APPROPRIATE' named entity 'TREATMENT' named entity 'INFECTION' named entity 'PATIENTS' named entity 'KIDNEY TRANSPLANT' named entity 'EVALUATION' named entity 'INFECTIONS' named entity 'RISK' named entity 'OPPORTUNISTIC INFECTIONS' named entity 'ADMITTED TO' named entity 'CHAPTER' named entity 'MANAGEMENT' named entity 'evaluation' named entity 'This' named entity 'Kidney Transplant' named entity 'renal transplant' named entity 'intensive care unit' named entity 'intensive care unit' named entity 'Kidney Transplant' named entity 'brincidofovir' named entity 'echinocandins' named entity 'SSI' named entity 'mycobacterial' named entity 'RTRs' named entity 'ascites' named entity 'RTRs' named entity 'kidney transplant' named entity 'diphtheria' named entity 'airborne transmission' named entity 'CNS' named entity 'viremia' named entity 'Escherichia coli' named entity 'DFA' named entity 'intravenous' named entity 'viral shedding' named entity 'PCR' named entity 'IgG' named entity 'infection' named entity 'Adenovirus' named entity 'human metapneumovirus' named entity 'nucleic acid testing' named entity 'nephrotoxicity' named entity 'HIV' named entity 'GI tract' named entity 'valganciclovir' named entity 'dysphagia' named entity 'urinary tract' named entity 'bodily fluids' named entity 'HHV-6' named entity 'HSV' named entity 'infection' named entity 'urinary tract infections' named entity 'blood cultures' named entity 'CDI' named entity 'Candida' named entity 'rhinovirus' named entity 'histopathology' named entity 'PJP' named entity 'fluconazole' named entity 'myelosuppression' named entity 'latent tuberculosis' named entity 'coccidiomycosis' named entity 'antimicrobial therapy' named entity 'yeast' named entity 'Rhizomucor' named entity 'prophylaxis' named entity 'medical history' named entity 'diagnostic test' named entity 'abscesses' named entity 'RSV' named entity 'opportunistic pathogens' named entity 'long-term' named entity 'odynophagia' named entity 'HSV' named entity 'intranuclear inclusions'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software